Fresenius Helios completed today its acquisition of a 519-bed municipal hospital in the German state of North Rhine-Westphalia. Located in the city of Velbert, the hospital had 2015 sales of about €69 million. The acquisition, which was announced in February, will be accretive to Fresenius Group earnings from this year.

Chloramphenicol Sodium Succinate Injection, an antibiotic, expands Fresenius Kabi's anti-infective portfolio.

Linezolid injection further expands the Fresenius Kabi anti-infective portfolio. It is available in the company's proprietary Freeflex® bag.

University Hospital of Munich has joined the growing “Wir für Gesundheit” hospital network, becoming the first university clinic to accept PlusCard. Through its supplementary company health insurance, PlusCard offers employers coverage options that provide employees with different levels of service and comfort. “Wir für Gesundheit” was formed by hospital operators Asklepios, Fresenius Helios and Rhön, and has more than 120 partner hospitals in Germany committed to quality standards far higher than those required by law.

Vamed is realizing the new main building of University Hospital Schleswig-Holstein in Kiel, Germany as part of a public-private partnership. The company will also be responsible for the long-term technical management of the building, which will house more than 600 beds and 22 operating rooms. The work is part of a comprehensive construction and modernization project at the hospital. Completion is scheduled for 2019.

Amikacin Sulfate Injection, an antibiotic, expands Fresenius Kabi's anti-infective portfolio.